Literature DB >> 32157790

Impact of obesity on the increasing incidence of type 1 diabetes.

Raffaella Buzzetti1, Simona Zampetti1, Paolo Pozzilli2,3.   

Abstract

Published estimates of the incidence of type 1 diabetes (T1D) in children in the last decade varies between 2% and 4% per annum. If this trend continued, the disease incidence would double in the next 20 years. The risk of developing T1D is determined by a complex interaction between multiple genes (mainly human leukocyte antigens) and environmental factors. Notwithstanding that genetic susceptibility represents a relevant element in T1D risk, genetics alone cannot explain the increase in incidence. Various environmental factors have been suggested as potential triggers for T1D, including several viruses and the hygiene hypothesis; however, none of these seems to explain the large increase in T1D incidence observed over the last decades. Several studies have demonstrated that the prevalence of childhood/adolescence overweight and obesity has risen during the past 30 years in T1D. Currently, at diagnosis, the majority of patients with T1D have normal or elevated body weight and ~50% of patients with longstanding T1D are either overweight or obese. The growing prevalence of obesity in childhood and adolescence offers a plausible explanation for the increase in T1D incidence observed in recent decades. Possible mechanisms of the enhancement of β-cell autoimmunity by obesity include: a) insulin resistance-induced β-cell secretory demand triggering autoimmunity through cytokine release, neo-epitope antigen formation and increase in β-cell apoptosis, and b) obesity-induced low-grade inflammation with pro-inflammatory cytokines secreted by locally infiltrating macrophages, which contribute to the presentation by islet cells of autoantigens generally not accessible to T cells. Further studies are needed to clarify whether the control of body weight can prevent or delay the current and continuing rise in T1D incidence.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  beta cell function; glycaemic control; type 1 diabetes

Mesh:

Year:  2020        PMID: 32157790     DOI: 10.1111/dom.14022

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  6 in total

Review 1.  Adult-onset autoimmune diabetes.

Authors:  Raffaella Buzzetti; Ernesto Maddaloni; Jason Gaglia; R David Leslie; F Susan Wong; Bernhard O Boehm
Journal:  Nat Rev Dis Primers       Date:  2022-09-22       Impact factor: 65.038

2.  The relation between prenatal stress, overweight and obesity in children diagnosed according to BMI and percentage fat tissue.

Authors:  Ewa Bryl; Tomasz Hanć; Paula Szcześniewska; Agata Dutkiewicz; Monika Dmitrzak-Węglarz; Agnieszka Słopień
Journal:  Eat Weight Disord       Date:  2022-06-12       Impact factor: 3.008

Review 3.  The Challenges of Identifying Environmental Determinants of Type 1 Diabetes: In Search of the Holy Grail.

Authors:  Sonia Butalia; Gilaad G Kaplan; Bushra Khokhar; Sydney Haubrich; Doreen M Rabi
Journal:  Diabetes Metab Syndr Obes       Date:  2020-12-09       Impact factor: 3.168

4.  The association between overweight/obesity and double diabetes in adults with type 1 diabetes; a cross-sectional study.

Authors:  Nathan Wp Cantley; Kathryn Lonnen; Ioannis Kyrou; Abd A Tahrani; Hassan Kahal
Journal:  BMC Endocr Disord       Date:  2021-09-16       Impact factor: 2.763

5.  The Influence of Doing Shift Work on the Lifestyle Habits of Primary Care Nurses.

Authors:  Iris Forcada-Parrilla; Glòria Reig-Garcia; Laura Serra; Dolors Juvinyà-Canal
Journal:  Nurs Rep       Date:  2022-04-12

Review 6.  C-peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective.

Authors:  Ernesto Maddaloni; Geremia B Bolli; Brian M Frier; Randie R Little; Richard D Leslie; Paolo Pozzilli; Raffaela Buzzetti
Journal:  Diabetes Obes Metab       Date:  2022-06-28       Impact factor: 6.408

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.